CS logo
small CS logo
Asklepios Kllinikum Bad Abbach; Klinik für Rheumatologie und Klinische Immunologie

Bad Abbach, Germany

About Asklepios Kllinikum Bad Abbach; Klinik für Rheumatologie und Klinische Immunologie


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
No rows

Clinical Trials at Asklepios Kllinikum Bad Abbach; Klinik für Rheumatologie und Klinische Immunologie


During the past decade, Asklepios Kllinikum Bad Abbach; Klinik für Rheumatologie und Klinische Immunologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
No rows

Rows per page:

0–0 of 0

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Asklepios Kllinikum Bad Abbach; Klinik für Rheumatologie und Klinische Immunologie


According to Clinical.Site data, the most researched conditions in "Asklepios Kllinikum Bad Abbach; Klinik für Rheumatologie und Klinische Immunologie" are "Giant Cell Arteritis" (1 trials), "Rheumatoid Arthritis" (1 trials) and "Systemic Sclerosis" (1 trials). Many other conditions were trialed in "Asklepios Kllinikum Bad Abbach; Klinik für Rheumatologie und Klinische Immunologie" in a lesser frequency.

Clinical Trials Intervention Types at Asklepios Kllinikum Bad Abbach; Klinik für Rheumatologie und Klinische Immunologie


Most popular intervention types in "Asklepios Kllinikum Bad Abbach; Klinik für Rheumatologie und Klinische Immunologie" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Tocilizumab" (3 trials), "Prednisone" (2 trials), "Corticosteroids" (1 trials), "Methotrexate" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Asklepios Kllinikum Bad Abbach; Klinik für Rheumatologie und Klinische Immunologie


The vast majority of trials in "Asklepios Kllinikum Bad Abbach; Klinik für Rheumatologie und Klinische Immunologie" are 3 trials for "All" genders.

Clinical Trials Status at Asklepios Kllinikum Bad Abbach; Klinik für Rheumatologie und Klinische Immunologie


Currently, there are NaN active trials in "Asklepios Kllinikum Bad Abbach; Klinik für Rheumatologie und Klinische Immunologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Asklepios Kllinikum Bad Abbach; Klinik für Rheumatologie und Klinische Immunologie, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Asklepios Kllinikum Bad Abbach; Klinik für Rheumatologie und Klinische Immunologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status